Friday, April 26, 2024
Advertisement
Updated on: May 13, 2021 11:20 IST

DCGI approves Covaxin for phase 2/3 trials on children

The DGCI has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between two to 18 years. The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

Latest Videos

Advertisement
Advertisement
Advertisement
Advertisement